MoneyWorks4Me

Lupin informs about investors meet

11 Jan 2023 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A(15) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed the investor presentation which will be made at the J. P Morgan Healthcare Conference, US on January 10, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.75
Dr. Reddys Labs. 1321.00
Cipla 1364.90
Lupin 1958.30
Zydus Lifesciences 1171.35
View more..